drugset / Trial / NCT00921102

Atropine to Prevent Nausea and Vomiting After Spinal Anesthesia for Caesarean Section

NCT00921102

Phase 4 Completed 216 enrolled University of Parma
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to assess the efficacy of atropine in preventing nausea and vomiting after spinal anesthesia with local anesthetic and morphine for elective Caesarean section. Patients enrolling in the study will be assigned to one of three groups. One will receive a small dose of intrathecal atropine; another will receive small-dose intravenous atropine; the third group will receive placebo.

Timeline

Start
2007-05
Primary completion
2008-02
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Atropine Other / unclassified 100 ug Intrathecal
Background Bupivacaine Other / unclassified 12.5 mg Intrathecal
Background Morphine Other / unclassified 200 ug Intrathecal

Indications

No indication recorded.